Zobrazeno 1 - 10
of 197
pro vyhledávání: '"C. A. Finn"'
Autor:
K. Haslett, P. Koh, A. Hudson, W.D. Ryder, S. Falk, D. Mullan, B. Taylor, R. Califano, F. Blackhall, C. Faivre-Finn
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss , Pp 24-31 (2021)
Background: The RAS/RAF/MEK/ERK signalling pathway has a pivotal role in cancer proliferation and modulating treatment response. Selumetinib inhibits MEK and enhances effects of radiotherapy in preclinical studies. Patients and methods: Single-arm, s
Externí odkaz:
https://doaj.org/article/0d7c9236c85e451592fe459e13933f3c
Publikováno v:
Radiotherapy and Oncology. 170:S1422-S1425
Publikováno v:
Radiotherapy and Oncology. 170:S605-S607
Publikováno v:
Radiotherapy and Oncology. 170:S327-S329
Publikováno v:
Radiotherapy and Oncology. 170:S331-S333
Publikováno v:
Radiotherapy and Oncology. 170:S608-S610
Autor:
I.S. Voruganti, C.A.E. Cunningham, L. McLeod, N. Chaudhuri, K.L.M. Chua, M. Evison, C. Faivre-Finn, K.N. Franks, S. Harden, J. Kruser, T. Kruser, P. Lee, C. Peedell, I. Phillips, C.G. Robinson, S. Senan, G.M. Videtic, A. Wright, S. Harrow, A.V. Louie
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:e364-e365
Autor:
S. Cooke, D. de Ruysscher, B. Reymen, M. Lambrecht, G. Fredberg Persson, C. Faivre-Finn, E.M. Dieleman, J. van Diessen, E. Damen, K. Sikorska, J. Belderbos, J.J. Sonke
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:e369-e370
Autor:
H.M. Hanson, M. Dubec, S. Brown, M.C. Aznar, L. McDaid, C. Faivre-Finn, M. van Herk, B.C. Rowland
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:e97-e98
Autor:
A. Passaro, N. Leighl, F. Blackhall, S. Popat, K. Kerr, M.J. Ahn, M.E. Arcila, O. Arrieta, D. Planchard, F. de Marinis, A.M. Dingemans, R. Dziadziuszko, C. Faivre-Finn, J. Feldman, E. Felip, G. Curigliano, R. Herbst, P.A. Jänne, T. John, T. Mitsudomi, T. Mok, N. Normanno, L. Paz-Ares, S. Ramalingam, L. Sequist, J. Vansteenkiste, I.I. Wistuba, J. Wolf, Y.L. Wu, S.R. Yang, J.C.H. Yang, Y. Yatabe, G. Pentheroudakis, S. Peters
Publikováno v:
Annals of Oncology, 33(5), 466-487. Elsevier Ltd.
Passaro, A, Leighl, N, Blackhall, F, Popat, S, Kerr, K, Ahn, M J, Arcila, M E, Arrieta, O, Planchard, D, de Marinis, F, Dingemans, A M, Dziadziuszko, R, Faivre-Finn, C, Feldman, J, Felip, E, Curigliano, G, Herbst, R, Jänne, P A, John, T, Mitsudomi, T, Mok, T, Normanno, N, Paz-Ares, L, Ramalingam, S, Sequist, L, Vansteenkiste, J, Wistuba, I I, Wolf, J, Wu, Y L, Yang, S R, Yang, J C H, Yatabe, Y, Pentheroudakis, G & Peters, S 2022, ' ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer ', Annals of Oncology, vol. 33, no. 5, pp. 466-487 . https://doi.org/10.1016/j.annonc.2022.02.003
Passaro, A, Leighl, N, Blackhall, F, Popat, S, Kerr, K, Ahn, M J, Arcila, M E, Arrieta, O, Planchard, D, de Marinis, F, Dingemans, A M, Dziadziuszko, R, Faivre-Finn, C, Feldman, J, Felip, E, Curigliano, G, Herbst, R, Jänne, P A, John, T, Mitsudomi, T, Mok, T, Normanno, N, Paz-Ares, L, Ramalingam, S, Sequist, L, Vansteenkiste, J, Wistuba, I I, Wolf, J, Wu, Y L, Yang, S R, Yang, J C H, Yatabe, Y, Pentheroudakis, G & Peters, S 2022, ' ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer ', Annals of Oncology, vol. 33, no. 5, pp. 466-487 . https://doi.org/10.1016/j.annonc.2022.02.003
The European Society for Medical Oncology (ESMO) held a virtual consensus-building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer in 2021. The consensus included a multidisciplinary panel of 34 leading experts in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2db549ac429690db378bd3cb257d9b
https://pure.eur.nl/en/publications/f59acf79-8386-4d0a-82e7-51e8987bea14
https://pure.eur.nl/en/publications/f59acf79-8386-4d0a-82e7-51e8987bea14